Myriad Genetics Inc
MYGN3.890USD
-0.140-3.47%
收盘 05/09, 16:00（美东）报价延迟15分钟
358.66M总市值
亏损市盈率 TTM
关于 Myriad Genetics Inc 公司
Myriad Genetics, Inc. 是一家基因检测和精准医疗公司。该公司开发并提供基因检测，帮助评估患病或疾病进展的风险，并指导各个医学专业的治疗决策，其中基因洞察可以显著改善患者护理并降低医疗成本。该公司专注于三个关键领域，在这些领域拥有专门的产品、能力和专业知识：肿瘤学、女性健康和心理健康。在肿瘤学领域，该公司为癌症患者提供检测，并提供与相应药物和治疗配合使用的伴随诊断测试。它还提供 SneakPeek 早期性别 DNA 测试，可以在怀孕六周后揭示婴儿的性别。该公司的检测产品包括 MyRisk、BRACAnalysis、BRACAnalysis CDx、MyChoice CDx、Prolaris、Foresight、Prequel、Precis Tumor Test、Precise Liquid Test、SneakPeek 和 GeneSight 等。
公司简介
公司代码MYGN
公司名称Myriad Genetics Inc
上市日期Oct 06, 1995
成立日期1992
CEOMr. Samraat S. (Sam) Raha
员工数量2700
证券类型Ordinary Share
年结日Oct 06
公司地址322 North 2200 West
城市SALT LAKE CITY
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编84116
电话18015843600
网址https://myriad.com/
公司代码MYGN
上市日期Oct 06, 1995
成立日期1992
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
82.34K
--
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
77.39K
--
Dr. Dale Muzzey
Dr. Dale Muzzey
Chief Scientific Officer
Chief Scientific Officer
45.88K
-46.96%
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matt Scalo
Mr. Matt Scalo
Investor Relations
Investor Relations
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Chief Legal Officer
Chief Legal Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Brian Donnelly
Mr. Brian Donnelly
Chief Commercial Officer
Chief Commercial Officer
397.53K
--
Mr. Mark S. Verratti
Mr. Mark S. Verratti
Chief Operating Officer and Chief Commercial Officer
Chief Operating Officer and Chief Commercial Officer
221.65K
-11.52%
Ms. Margaret (Maggie) Ancona
Ms. Margaret (Maggie) Ancona
Senior Vice President, Chief of Staff
Senior Vice President, Chief of Staff
128.68K
+56.61%
Ms. Shereen Solaiman
Ms. Shereen Solaiman
Chief People Officer
Chief People Officer
110.96K
+98.89%
Dr. Lee Nisley Newcomer, M.D.
Dr. Lee Nisley Newcomer, M.D.
Independent Director
Independent Director
82.34K
--
Ms. Rashmi Kumar
Ms. Rashmi Kumar
Independent Director
Independent Director
77.39K
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
业务USD
名称
营收
占比
Hereditary Cancer
364.50M
43.52%
Prenatal
177.10M
21.14%
Pharmacogenomics
170.20M
20.32%
Tumor Profiling
125.80M
15.02%
地区USD
名称
营收
占比
United States
769.50M
91.87%
Rest of world
68.10M
8.13%
业务
地区
业务USD
名称
营收
占比
Hereditary Cancer
364.50M
43.52%
Prenatal
177.10M
21.14%
Pharmacogenomics
170.20M
20.32%
Tumor Profiling
125.80M
15.02%
股东统计
更新时间: 5月4日 周日
更新时间: 5月4日 周日
持股股东
股东类型
持股股东
股东统计
占比
BlackRock Institutional Trust Company, N.A.
15.02%
The Vanguard Group, Inc.
11.52%
Wellington Management Company, LLP
6.51%
State Street Global Advisors (US)
5.99%
Millennium Management LLC
4.71%
Other
56.24%
持股股东
股东统计
占比
BlackRock Institutional Trust Company, N.A.
15.02%
The Vanguard Group, Inc.
11.52%
Wellington Management Company, LLP
6.51%
State Street Global Advisors (US)
5.99%
Millennium Management LLC
4.71%
Other
56.24%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
43.56%
Investment Advisor
34.86%
Hedge Fund
18.62%
Individual Investor
2.85%
Research Firm
2.64%
Pension Fund
1.14%
Bank and Trust
0.40%
Sovereign Wealth Fund
0.10%
Insurance Company
0.04%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
510
96.13M
104.30%
-2.66M
2024Q4
516
96.89M
106.12%
-1.41M
2024Q3
505
95.02M
104.61%
-5.50M
2024Q2
486
96.79M
106.52%
-6.22M
2024Q1
460
98.19M
108.68%
+613.48K
2023Q4
464
93.46M
105.77%
+2.70M
2023Q3
471
86.01M
104.78%
-3.73M
2023Q2
480
84.60M
103.32%
-6.34M
2023Q1
483
85.87M
105.37%
-2.69M
2022Q4
490
83.72M
103.14%
-4.93M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
14.32M
15.68%
+446.35K
+3.22%
Dec 31, 2024
The Vanguard Group, Inc.
10.57M
11.58%
+279.38K
+2.71%
Dec 31, 2024
Wellington Management Company, LLP
6.00M
6.58%
-711.99K
-10.60%
Dec 31, 2024
State Street Global Advisors (US)
5.53M
6.05%
+822.26K
+17.48%
Dec 31, 2024
Millennium Management LLC
4.35M
4.76%
-831.32K
-16.06%
Dec 31, 2024
Glenview Capital Management, LLC
4.16M
4.55%
+2.90M
+229.55%
Dec 31, 2024
EARNEST Partners, LLC
3.97M
4.35%
+15.65K
+0.40%
Dec 31, 2024
Camber Capital Management LP
3.10M
3.4%
-850.00K
-21.52%
Dec 31, 2024
Artisan Partners Limited Partnership
2.77M
3.03%
+336.77K
+13.86%
Dec 31, 2024
Disciplined Growth Investors, Inc.
2.56M
2.8%
+29.14K
+1.15%
Dec 31, 2024
查看更多
持股ETF
更新时间: 5月6日 周二
更新时间: 5月6日 周二
机构名称
占比
Invesco Biotechnology & Genome ETF
1.95%
Global X Genomics & Biotechnology ETF
1.64%
WisdomTree BioRevolution Fund
0.64%
Invesco S&P SmallCap Health Care ETF
0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.31%
SPDR S&P Biotech ETF
0.27%
Strategas Global Policy Opportunities ETF
0.18%
Direxion Daily S&P Biotech Bull 3X Shares
0.17%
Inspire Small/Mid Cap ESG ETF
0.14%
SPDR S&P 600 Small Cap Value ETF
0.12%
查看更多
Invesco Biotechnology & Genome ETF
占比1.95%
Global X Genomics & Biotechnology ETF
占比1.64%
WisdomTree BioRevolution Fund
占比0.64%
Invesco S&P SmallCap Health Care ETF
占比0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.31%
SPDR S&P Biotech ETF
占比0.27%
Strategas Global Policy Opportunities ETF
占比0.18%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.17%
Inspire Small/Mid Cap ESG ETF
占比0.14%
SPDR S&P 600 Small Cap Value ETF
占比0.12%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据